The latest updates on prescription drugs and ways to save from the GoodRx medical team

Recall of Estarylla

by Elizabeth Davis on July 8, 2013 at 10:27 am

Sandoz, the manufacturer of Estarylla (norgestimate and ethinyl estradiol) contraceptive tablets has issued a voluntary recall of one lot of the tablets.

A customer reported a placebo pill out of place in the active tablet area of the Estarylla monthly pack. While the risk of pregnancy or other adverse health effects is low, the recall is being conducted as a precaution.

You can tell if your package may be part of the recalled lot, LF01213A, if it has an NDC number 00781-4058-15 and expiration date of 02/2014. The recall is at the retailer level though, so you shouldn’t receive any Estarylla from the recalled lot from your pharmacy in future refills.

If you experience any reaction or quality issue with Estarylla, contact your doctor or pharmacist. Sandoz also asks that you report any issues to them through their drug information line at 1-800-525-2492 or via email at qa.druginfo@sandoz.com.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.